Key Highlights
- Veradigm Inc. collaborates with the American College of Cardiology (ACC) to launch TRANSFORM VAX, focusing on improving heart health via flu vaccination education.
- Significant reduction in cardiovascular risks associated with flu vaccination, including a 34% decrease in major adverse events.
- The initiative leverages Veradigm’s real-world data and the Practice Fusion EHR network to deliver ACC-sponsored educational messages to cardiology practices.
Source: Business Wire
Notable Quotes
- “People with heart disease have a much higher risk of serious complications from the flu, including heart attack, stroke, and heart failure,” – Ami Bhatt, MD, Chief Innovation Officer at American College of Cardiology (ACC)
- “Veradigm is proud to be working with the ACC to apply our real-world data in combination with our messaging capabilities to improve rates of recommended vaccinations for adults with cardiovascular disease,” – Stuart Green, Senior Vice President and General Manager at Veradigm
- “Together with Veradigm, the ACC is studying how to reach clinicians in innovative ways to provide timely, actionable information to close implementation gaps in influenza vaccination for at-risk cardiovascular patients,” – Ankeet S. Bhatt, MD, MBA, ScM, Chair at the TRANSFORM VAX project steering committee
SoHC's Take
The partnership between Veradigm Inc. and the American College of Cardiology (ACC) on the TRANSFORM VAX initiative is a strategic step towards enhancing cardiovascular health through proactive influenza vaccination. This collaboration highlights the importance of leveraging technology and real-world data to educate healthcare providers and improve vaccination rates among those at higher risk of adverse cardiovascular events. The significant reduction in cardiovascular risks associated with flu vaccination, as demonstrated by recent studies, underscores the potential of targeted educational initiatives like TRANSFORM VAX in closing the gap between evidence-based recommendations and real-world practice. This effort not only aims to protect individuals with cardiovascular disease from the flu’s complications but also sets a benchmark for future quality improvement successes in healthcare.
